|
Volumn 18, Issue 1, 2006, Pages 73-81
|
Randomized study of concurrent carboplatin, paclitaxel, and radiotherapy with or without prior induction chemotherapy in patients with locally advanced non-small cell lung cancer.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CARBOPLATIN;
PACLITAXEL;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
LUNG NON SMALL CELL CANCER;
LUNG TUMOR;
MALE;
MIDDLE AGED;
MORTALITY;
MULTICENTER STUDY;
MULTIMODALITY CANCER THERAPY;
RADIOTHERAPY;
RANDOMIZED CONTROLLED TRIAL;
SURVIVAL;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARBOPLATIN;
CARCINOMA, NON-SMALL-CELL LUNG;
COMBINED MODALITY THERAPY;
FEMALE;
HUMANS;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
PACLITAXEL;
RADIOTHERAPY;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
EID: 34249862380
PISSN: 11100362
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (14)
|
References (0)
|